Caregiver burden and risk of epithelial ovarian cancer in the Nurses' Health Studies
- PMID: 38973733
- PMCID: PMC11815502
- DOI: 10.1093/aje/kwae185
Caregiver burden and risk of epithelial ovarian cancer in the Nurses' Health Studies
Abstract
Psychosocial stress may increase ovarian cancer risk and accelerate disease progression. We examined the association between caregiver burden, a common stressor, and risk of epithelial ovarian cancer. We prospectively followed 67 724 women in the Nurses' Health Study (1992-2012) and 70 720 women in the Nurses' Health Study II (2001-2009) who answered questions on informal caregiving (ie, caregiving outside of work). Women who reported no informal caregiving were considered noncaregivers, while, among women who provided care outside of work, caregiver burden was categorized by time spent caregiving and perceived stress from caregiving. For the 34% of women who provided informal care for ≥15 hours per week, 42% described caregiving as moderately to extremely stressful. Pooled multivariate analyses indicated no difference in ovarian cancer risk for women providing ≥15 hours of care per week compared to noncaregivers (hazard ratio [HR] = 0.96; 95% confidence interval [CI], 0.79-1.18), and no association was evident for women who reported moderate or extreme stress from caregiving compared to noncaregivers (HR = 0.96; 95% CI, 0.75-1.22). Together with prior work evaluating job strain and ovarian cancer risk, our findings suggest that, when evaluating a stressor's role in cancer risk, it is critical to consider how the stressor contributes to the overall experience of distress. This article is part of a Special Collection on Gynecological Cancer.
Keywords: caregiver; epidemiology; ovarian cancer; psychological stress.
© The Author(s) 2024. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Conflict of interest statement
Anil K. Sood: consulting (Merck, Kiyatec); shareholder (BioPath); research support (MTrap).
Similar articles
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article.
-
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3. Cochrane Database Syst Rev. 2022. PMID: 35866378 Free PMC article.
-
Optimal primary surgical treatment for advanced epithelial ovarian cancer.Cochrane Database Syst Rev. 2011 Aug 10;2011(8):CD007565. doi: 10.1002/14651858.CD007565.pub2. Cochrane Database Syst Rev. 2011. PMID: 21833960 Free PMC article.
-
Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.Cochrane Database Syst Rev. 2022 Feb 16;2(2):CD007929. doi: 10.1002/14651858.CD007929.pub4. Cochrane Database Syst Rev. 2022. PMID: 35170751 Free PMC article.
-
Angiogenesis inhibitors for the treatment of epithelial ovarian cancer.Cochrane Database Syst Rev. 2023 Apr 18;4(4):CD007930. doi: 10.1002/14651858.CD007930.pub3. Cochrane Database Syst Rev. 2023. PMID: 37185961 Free PMC article.
References
-
- National Alliance for Caregiving and AARP . Caregiving in the U.S.: 2015. Accessed July 14, 2016. http://www.aarp.org/content/dam/aarp/ppi/2015/caregiving-in-the-united-s...
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical